Researchers from Shanghai Pulmonary Hospital and elsewhere take a look at the main B cell subtypes that interact with non-small cell lung cancer (NSCLC) tumors. Using single-cell transcriptome sequencing, flow cytometry-based cell sorting, immunohistochemistry, and other approaches, the team assessed samples from more than 150 NSCLC cases.